V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320003810 | 320002320 | 1.69 | 75 | Palliative (P) | 2017-09-28 | 2017-10-09 | Dacarbazine | N | N | 320003787 | NIVOLUMAB |
| 320003811 | 320002320 | 1.72 | 80 | Palliative (P) | 2018-09-03 | 2018-09-05 | CETUXIMAB + RT | N | N | 320003787 | BLEOMYCIN + CISPLATIN + MTOMYCIN |
| 320003812 | 320002321 | 1.72 | null | Palliative (P) | 2017-05-17 | 2017-08-19 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 320003872 | ICON TRIAL |
| 320003813 | 320002322 | null | null | Curative (C) | 2017-12-25 | 2017-12-28 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 320004027 | OXALIPLATIN + MDG |
| 320003814 | 320002323 | 1.78 | 53 | Curative (C) | 2015-01-13 | 2015-01-13 | CVP R | 2 | N | 320004049 | PACLITAXEL |
| 320003815 | 320002324 | 1.52 | 66.8 | Disease modification (D) | null | 2015-05-17 | EVEROLIMUS | N | N | 320004095 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320003816 | 320002324 | null | 75 | Palliative (P) | 2017-02-23 | 2017-03-02 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 320004095 | CARBO + FLUOROURACIL |
| 320003817 | 320002325 | 1.48 | 121 | Adjuvant (A) | 2017-10-11 | 2017-11-01 | Trial Unspecified | N | Y | 320004420 | TRABECTEDIN |
| 320003818 | 320002326 | 1.78 | 52.3 | Palliative (P) | 2018-12-29 | 2018-12-29 | CETUXIMAB + RT | 2 | N | 320004516 | OXALIPLATIN + MDG |
| 320003819 | 320002327 | 1.72 | 84.5 | Palliative (P) | 2016-07-02 | 2016-07-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320004590 | CETUXIMAB + RT |
| 320003820 | 320002328 | 1.72 | 42 | Adjuvant (A) | 2017-03-07 | 2017-03-12 | Trial Unspecified | 02 | N | 320004672 | CARBOPLATIN + ETOPOSIDE |
| 320003821 | 320002328 | 1.68 | 79.4 | Curative (C) | 2018-10-24 | 2018-10-24 | Cisplatin + Docetaxel +Fluorouracil | 01 | null | 320004672 | CISPLATIN + GEMCITABINE |
| 320003822 | 320002328 | 1.71 | 59.4 | Curative (C) | 2014-08-06 | 2014-09-18 | Carbo + Liposomal Dox + Paclitaxel | 02 | N | 320004672 | NOT MATCHED |
| 320003823 | 320002328 | 1.58 | 61.7 | Palliative (P) | 2016-07-20 | 2016-08-22 | null | 02 | null | 320004672 | NOT MATCHED |
| 320003824 | 320002328 | 1.74 | 69.6 | Adjuvant (A) | null | 2018-04-30 | Carbo F | N | N | 320004672 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003825 | 320002329 | 1.57 | 48.4 | null | 2015-10-25 | 2015-11-07 | Cisplatin + Docetaxel | null | null | 320004866 | NOT MATCHED |
| 320003826 | 320002329 | 1.66 | 86.4 | Palliative (P) | 2017-09-08 | 2017-09-15 | Cisplatin+Gemcitabine (gallbladder) | 2 | N | 320004866 | MMM |
| 320003827 | 320002330 | 1.83 | 104 | Curative (C) | 2013-11-15 | 2013-12-06 | Bevacizumab 5mg/kg | N | Y | 320004917 | TRIAL |
| 320003828 | 320002331 | 1.8 | 96.2 | Palliative (P) | 2017-04-10 | 2017-05-01 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 320005032 | FEC + DOCETAXEL |
| 320003829 | 320002332 | 1.86 | 132.599 | Curative (C) | 2015-12-27 | 2015-12-27 | Carbo F | N | N | 320005041 | RUXOLITINIB |
| 320003830 | 320002333 | 1.61 | 145 | Palliative (P) | 2016-10-10 | 2016-10-17 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 320005162 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320003831 | 320002333 | 1.71 | 78.8 | Palliative (P) | 2013-06-03 | 2013-06-03 | CNS Choriod Plexus SIOP 2009 CarbEV | N | null | 320005162 | DOCETAXEL |
| 320003832 | 320006380 | 1.83 | 102 | Palliative (P) | null | 2016-06-24 | PEMBROLIZUMAB | N | N | 320005261 | CAPECITABINE |
| 320003833 | 320006380 | 1.8 | 124 | Palliative (P) | 2018-04-01 | 2018-04-12 | Ipilimumab | 02 | N | 320005261 | CISPLATIN + GEMCITABINE |
| 320003834 | 320002334 | 1.48 | 48 | Curative (C) | 2018-04-17 | 2018-05-15 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 320005426 | ICON TRIAL |
| 320003835 | 320002334 | 1.84 | 84.4 | Palliative (P) | 2018-02-17 | 2018-03-18 | CISPLATIN + GEMCITABINE | N | N | 320005426 | CETUXIMAB + RT |
| 320003836 | 320002335 | 1.8 | 78.5 | Neo-adjuvant (N) | 2017-06-17 | 2017-06-17 | BCG Intravesical | N | N | 320005537 | CETUXIMAB + RT |
| 320003837 | 320002336 | 1.69 | 72 | Palliative (P) | 2017-08-06 | 2017-08-07 | Cisplatin + Etoposide po&iv 3 day | N | N | 320005621 | TEMOZOLOMIDE |
| 320003838 | 320002337 | 1.67 | null | null | 2017-02-14 | 2017-02-22 | Carbo F | N | N | 320005747 | CARBO + FLUOROURACIL |
| 320003839 | 320002337 | 1.62 | 65 | null | 2016-02-22 | 2016-02-22 | BCG Intravesical | 02 | N | 320005747 | CARBOPLATIN + PEMETREXED |
| 320003840 | 320002338 | 1.68 | 96 | Neo-adjuvant (N) | 2017-11-16 | 2017-11-25 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320006001 | FLUOROURACIL + MITOMYCIN |
| 320003841 | 320002339 | 1.55 | 57.3 | Neo-adjuvant (N) | 2013-03-22 | 2013-04-10 | FLUOROURACIL + IRINOTECAN | N | N | 320006091 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003842 | 320002340 | 1.69 | null | Curative (C) | 2017-08-26 | 2017-08-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 320006192 | CARBOPLATIN + DOCETAXEL |
| 320003843 | 320002341 | 1.78 | 90 | Palliative (P) | 2016-04-16 | 2016-04-22 | Trial Unspecified | Y | N | 320006235 | CISPLATIN + GEMCITABINE |
| 320003844 | 320002342 | 1.85 | 84.4 | Palliative (P) | 2018-05-10 | 2018-05-23 | Trial Unspecified | 02 | N | 320006247 | CARBOPLATIN + RT |
| 320003845 | 320002343 | 1.6 | 67.5 | Palliative (P) | 2019-01-07 | 2019-01-19 | LANREOTIDE | N | N | 320006376 | ECX |
| 320003846 | 320002344 | null | 54.45 | Adjuvant (A) | 2014-11-21 | 2014-12-08 | CAP | 99 | Y | 320006395 | IMATINIB |
| 320003847 | 320002345 | 1.66 | 55.8 | Neo-adjuvant (N) | 2018-06-20 | 2018-06-20 | IPILIMUMAB + NIVOLUMAB | 02 | N | 320006406 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003848 | 320002345 | 1.63 | 54 | Palliative (P) | null | 2018-08-16 | Carboplatin + Etoposide IV 3 day | N | Y | 320006406 | GEMCITABINE |
| 320003849 | 320002345 | 1.8 | 74.6 | Palliative (P) | 2015-02-07 | 2015-02-18 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 320006406 | DE-ESCALATE TRIAL |
| 320003850 | 320002345 | 1.66 | 60.6 | Palliative (P) | 2015-07-03 | 2015-07-03 | THALIDOMIDE | N | N | 320006406 | CISPLATIN + GEMCITABINE |
| 320003851 | 320002346 | 1.6 | 62 | Neo-adjuvant (N) | 2016-10-02 | 2016-10-02 | ICON8B TRIAL | N | N | 320006569 | CISPLATIN + GEMCITABINE |
| 320003852 | 320002346 | 1.7 | null | Palliative (P) | 2017-02-02 | 2017-03-04 | Mitomycin Intravesical | null | N | 320006569 | CISPLATIN + ETOPOSIDE |
| 320003853 | 320002347 | 1.6 | 60 | Curative (C) | 2013-09-07 | 2013-09-27 | Capecitabine | N | N | 320006638 | IPILIMUMAB |
| 320003854 | 320002348 | 1.75 | 57 | Neo-adjuvant (N) | 2017-03-05 | 2017-03-08 | CARBOPLATIN + RT | 2 | N | 320006846 | CARBOPLATIN + RT |
| 320003855 | 320002349 | 1.64 | 64 | Neo-adjuvant (N) | 2016-03-26 | 2016-03-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320006873 | CISPLATIN + ETOPOSIDE |
| 320003856 | 320002350 | 1.67 | 48 | Curative (C) | null | 2016-07-16 | Capecitabine + Cisplatin | N | Y | 320006927 | LIPOSOMAL DOXORUBICIN |
| 320003857 | 320002351 | 1.86 | 70.5 | Disease modification (D) | 2016-08-17 | 2016-09-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320007012 | OXALIPLATIN + MDG |
| 320003858 | 320002352 | 1.84 | 89.6 | Neo-adjuvant (N) | 2017-02-10 | 2017-02-16 | GEMCITABINE | N | N | 320007190 | BCG |
| 320003859 | 320002353 | 1.78 | 77.3 | Curative (C) | 2017-04-17 | 2017-04-29 | CISPLATIN + GEMCITABINE | 2 | Y | 320007198 | FLUOROURACIL + MITOMYCIN + RT |